Island Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 18, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	109	33	10	8	12	23
Market Cap Growth	275.18%	238.62%	26.43%	-34.48%	-48.02%	-
Enterprise Value	102	29	9	4	6	23
Last Close Price	0.37	0.14	0.08	0.09	0.13	0.26
PS Ratio	917.20	277.97	7.74	-	-	-
PB Ratio	15.24	4.62	6.43	4.32	2.73	3.54
P/TBV Ratio	15.24	4.62	6.43	4.32	2.73	3.54
EV/Sales Ratio	-	244.39	7.37	-	-	-
Debt / Equity Ratio	-	-	0.28	-	-	-
Net Debt / Equity Ratio	-1.01	-1.01	-0.81	-1.12	-1.11	-1.01
Asset Turnover	0.02	0.02	0.55	-	-	-
Quick Ratio	22.09	22.09	2.44	7.64	8.28	27.53
Current Ratio	22.27	22.27	2.45	7.77	8.44	28.02
Return on Equity (ROE)	-90.37%	-90.37%	-173.37%	-92.75%	-48.65%	-66.48%
Return on Assets (ROA)	-49.16%	-49.16%	-77.59%	-52.32%	-30.44%	-40.29%
Return on Capital Employed (ROCE)	-55.30%	-55.30%	-188.50%	-162.90%	-65.10%	-33.40%
Earnings Yield	-3.59%	-11.86%	-29.34%	-36.66%	-22.12%	-9.38%
Buyback Yield / Dilution	-91.98%	-91.98%	-11.11%	-0.42%	-334.32%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.